Vanguard Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $718K | Buy |
|
|||||
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $416K | Buy |
|
|||||
2023
Q4 | $539K | Buy |
|
|||||
2023
Q3 | $467K | Buy |
|
|||||
2023
Q2 | $461K | Buy |
|
|||||
2014
Q4 | – | Sell |
|
|||||
2014
Q3 | $271K | Buy |
|
|||||
2014
Q2 | $335K | Sell |
|
|||||
2014
Q1 | $436K | Buy |
|
|||||
2013
Q4 | $297K | Buy |
|
|||||
2013
Q3 | $323K | Buy |
|
|||||
2013
Q2 | $322K | Buy |
|